Prot # ROF-NASH_205: A Randomized, Double-Blind, Controlled, Multi-Center Phase 2 Study to Evaluate the Effect of Roflumilast Plus Pioglitazone on Liver Enzymes and Liver Fat Content in Subjects with Nonalcoholic Steatohepatitis

Project: Research project

Project Details

StatusFinished
Effective start/end date2/11/142/11/17

Funding

  • Quintiles, Inc. (ROF-NASH_205 // ROF-NASH_205)
  • Takeda Development Center Americas, Inc. (ROF-NASH_205 // ROF-NASH_205)